GalNAc-T12 is an enzyme that plays a crucial role in the process of O-glycosylation, a type of protein post-translational modification that is essential for the proper function of many cellular proteins. As a member of the polypeptide N-acetylgalactosaminyltransferase (GalNAc-transferases) family, GalNAc-T12 is responsible for catalyzing the initial transfer of N-acetylgalactosamine to serine or threonine residues on proteins. This modification is not only pivotal for protein stability and localization but also for cell signaling and communication. The expression of GalNAc-T12 is a tightly regulated process within the cell, and several factors can modulate its expression levels, either enhancing or reducing its activity. Understanding the regulation of GalNAc-T12 is of significant interest in the field of cellular biochemistry, as it provides insights into the complex mechanisms governing protein glycosylation and its effects on cellular functions.
Chemical compounds can influence the expression of enzymes like GalNAc-T12, although the exact mechanisms of such regulation are often intricate and multifaceted. Certain activators may work at a genetic level to promote the transcription of the GalNAc-T12 gene. For instance, compounds such as retinoic acid can upregulate gene expression by interacting with specific nuclear receptors, which then bind to DNA and initiate transcription. Similarly, agents like forskolin can elevate intracellular cAMP, which may activate protein kinase A and lead to the phosphorylation of transcription factors that boost GalNAc-T12 expression. Other molecules, such as histone deacetylase inhibitors like trichostatin A, can alter chromatin structure, thereby increasing gene accessibility to transcriptional machinery and potentially leading to higher GalNAc-T12 levels. Moreover, substances such as 5-Azacytidine can induce expression by causing demethylation of the GalNAc-T12 gene promoter, while dexamethasone may activate specific transcription factors through its interaction with glucocorticoid receptors. These activators and their interactions with cellular components elucidate the complex network of regulation that controls the expression of enzymes critical for post-translational modification processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate GalNAc-T12 by binding to retinoic acid receptors, leading to transcriptional activation of genes involved in glycosylation processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could potentially induce GalNAc-T12 by causing demethylation of gene promoter regions, thereby facilitating the transcription of glycosyltransferase-related genes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may elevate GalNAc-T12 levels by preventing deacetylation of histones, thus permitting the transcription machinery greater access to the DNA coding for glycosyltransferases. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin might stimulate GalNAc-T12 synthesis by raising intracellular cAMP, which in turn can activate transcription factors binding to the cAMP response elements near the GalNAc-T12 gene. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA could enhance GalNAc-T12 expression by activating protein kinase C, which then triggers a cascade that leads to the activation of transcription factors specific for GalNAc-T12. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate may increase expression of GalNAc-T12 through its HDAC inhibitory activity, which leads to a more open chromatin structure and potential transcription of glycosylation enzymes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate could stimulate GalNAc-T12 production by activating signaling pathways that lead to the transcriptional activation of enzymes involved in the O-glycosylation pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
This glucocorticoid might enhance GalNAc-T12 levels by binding to glucocorticoid receptors which interact with DNA elements upstream of the GalNAc-T12 gene to promote transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3β, lithium chloride could indirectly stimulate the transcription factors that are responsible for the upregulation of GalNAc-T12 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol could stimulate the expression of GalNAc-T12 by binding to estrogen receptors that interact with the promoter regions of genes involved in cell signaling and glycosylation. | ||||||